Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination.
about
Palliative cytoreductive surgery and hyperthermic intraperitoneal chemoperfusion: current clinical practice or misnomer?Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy for colorectal cancer: survival outcomes and patient selectionOutcome following incomplete surgical cytoreduction combined with intraperitoneal chemotherapy for colorectal peritoneal metastasesTreatment of peritoneal metastases from colorectal cancerRole of surgery in colorectal cancer liver metastasesLooking up: Recent advances in understanding and treating peritoneal carcinomatosisEvaluation of best supportive care and systemic chemotherapy as treatment stratified according to the retrospective peritoneal surface disease severity score (PSDSS) for peritoneal carcinomatosis of colorectal origin.A systematic review of treatment guidelines for metastatic colorectal cancerEarly and long-term outcomes of patients undergoing liver resection and diaphragm excision for advanced colorectal liver metastases.Peritoneal carcinomatosis of gastrointestinal tumors: where are we now?Peritoneal carcinomatosis of colorectal origin.Gene therapy using therapeutic and diagnostic recombinant oncolytic vaccinia virus GLV-1h153 for management of colorectal peritoneal carcinomatosisCytoreductive surgery of colorectal peritoneal metastases: outcomes after complete cytoreductive surgery and systemic chemotherapy onlyOral gastrografin radiography for the evaluation of the functional impact of peritoneal carcinomatosis: Correlation with clinicopathological findings.Cytoreductive surgery (SRC) and hyperthermic intraperitoneal chemotherapy (HIPEC) for treatment of peritoneal carcinomatosis: Our initial experience and technical details.Proactive Management for Gastric, Colorectal and Appendiceal Malignancies: Preventing Peritoneal Metastases with Hyperthermic Intraperitoneal Chemotherapy (HIPEC).Peritoneal carcinomatosis: patients selection, perioperative complications and quality of life related to cytoreductive surgery and hyperthermic intraperitoneal chemotherapyA retrospective analysis of hyperthermic intraperitoneal chemotherapy for gastric cancer with peritoneal metastasis.Cytoreductive surgery and intraperitoneal chemotherapy for colorectal peritoneal and hepatic metastases: a case-control study.Role of stereotactic body radiotherapy for oligometastasis from colorectal cancer.The role of laparoscopy in peritoneal surface malignancies selected for hyperthermic intraperitoneal chemotherapy (HIPEC).Melphalan: a promising agent in patients undergoing cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Morbidity of the abdominal wall resection and reconstruction after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).Port-site metastases is an independent prognostic factor in patients with peritoneal carcinomatosis.Diagnostic Laparoscopy in the Pre-operative Assessment of Patients Undergoing Cytoreductive Surgery and HIPEC for Peritoneal Surface Malignancies.Intraperitoneal chemotherapy and cytoreductive surgery for peritoneal metastases coupled with curative treatment of colorectal liver metastases: an updated systematic review.Limited synchronous hepatic resection does not compromise peri-operative outcomes or survival after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy.Prognostic factors of intraperitoneal chemotherapy for peritoneal carcinomatosis of gastric cancer: A retrospective study from a single center.Selection of patients and staging of peritoneal surface malignanciesSurgical results of patients with peritoneal carcinomatosis treated with cytoreductive surgery using a new technique named aqua dissection.Preoperative assessment of peritoneal carcinomatosis: intraindividual comparison of 18F-FDG PET/CT and MRI.Identification of patients likely to benefit from metastasectomy in stage IV colorectal cancer.Extent of colorectal peritoneal carcinomatosis: attempt to define a threshold above which HIPEC does not offer survival benefit: a comparative study.Prognostic significance of lymph node metastases in patients with high-grade appendiceal cancer.Modest advances in survival for patients with colorectal-associated peritoneal carcinomatosis in the era of modern chemotherapy.Prophylactic hyperthermic intraperitoneal chemotherapy in patients with epithelial appendiceal neoplasms.Role of Imaging in Peritoneal Surface Malignancies.Ovarian Metastases of Colorectal Origin: Treatment Patterns and Factors Affecting Outcomes.A proposal of Brazilian Society of Surgical Oncology for standardizing cytoreductive surgery plus hypertermic intraperitoneal chemotherapy procedures in Brazil: pseudomixoma peritonei, appendiceal tumors and malignant peritoneal mesothelioma.Complete cytoreductive surgery plus HIPEC for peritoneal metastases from unusual cancer sites of origin: results from a worldwide analysis issue of the Peritoneal Surface Oncology Group International (PSOGI).
P2860
Q26768306-47DCC91A-5B19-4184-A072-202EBC9AD9B4Q26768376-62C69BA0-9FD7-4E0E-8695-6160A3EAA008Q26774607-42F26D57-072D-462D-8F5A-8C146FE147A9Q26783662-7B5658C3-8514-4EBF-A2A0-8A0C23B0F614Q26830444-639CCBB5-3473-4CBB-A6F1-EEEE83FA284EQ26849259-70E9E590-452F-43EB-8753-4ACD404280FCQ33777576-3A2FE652-DA2C-481C-B997-5C320272870EQ33995028-F71F1154-97EB-45AD-B1ED-986836D87694Q34251792-9090BEBF-F3BC-4C4C-90B3-345165A2BF39Q34366940-B7B5C941-9BDC-44D4-86A7-2B6A22DC4DCDQ34391090-3BA2047C-7BD9-4679-B293-9833FF03AC27Q35216296-748BA675-8CC1-4687-ACE4-50604C661001Q35234968-0C525FAA-E9D6-4040-978D-CE228057D2F1Q35954086-BD6CE380-9937-4636-A763-2983514C60D5Q36160064-F617206B-0981-432D-9AFE-C82BB6C7FA6EQ36758901-47A5147A-D012-4AFB-84D4-824FC9C4E4FBQ37090867-E5560096-15CA-44A8-805C-90541746F9D7Q37108203-5B5F340C-F242-4976-8B0E-56695451BBDAQ37285937-2F39C982-71D8-46F5-90A1-6CDAFBB44655Q37708013-D525BF38-49D3-4AD3-86AA-4D0395700F48Q38027027-A73634CC-1E5B-4DDE-98A4-04F128A464ADQ38166245-9D7F4E78-1762-4D49-8207-B4E740336682Q38253190-C5FFA512-BB48-4EC1-90ED-1622D92FA41FQ38260594-34763077-8BCC-4CD7-A2ED-95A82C85428FQ38804709-485DBE6F-5E1E-4117-8E71-8F4096C8CBB3Q39014341-DF5E0EAD-5722-4854-A031-427157CB0BB1Q40343261-D7C2F43B-E25E-447A-8214-04B96BBA3671Q40496581-5DB5B854-7F06-493F-8F42-85CEC652C623Q41132530-2D75AB9B-3159-4DD2-AF7D-6ED1D9295D0DQ41828967-35990F63-CC2C-4E89-B87D-274CF32F1264Q44076876-5433A6AF-3C06-4003-AB62-E66057CCD844Q44297884-C395ABE9-AA3A-48B7-BF81-6FCCE047156AQ44408342-012785A4-E47D-440A-8A3C-11214EDD21FDQ44646347-ED0310F5-E013-4F2A-96BC-822347A60594Q46793061-DFFCCE6B-A9F5-4B93-A5B1-00577012090DQ46924394-D57914CF-98CB-437D-A334-2D83C824AC98Q47155878-70F0C8AE-D519-46DC-BE85-25A12423534FQ47285140-ED7EF165-8534-478B-86DF-8AA9C321B787Q47821560-6CF70A69-39A4-4317-82B1-A67162AC2FB7Q48645092-8611863E-179B-44B0-BBE0-C48EB39E36B1
P2860
Consensus statement on the loco regional treatment of colorectal cancer with peritoneal dissemination.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on September 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Consensus statement on the loc ...... with peritoneal dissemination.
@en
Consensus statement on the loc ...... with peritoneal dissemination.
@nl
type
label
Consensus statement on the loc ...... with peritoneal dissemination.
@en
Consensus statement on the loc ...... with peritoneal dissemination.
@nl
prefLabel
Consensus statement on the loc ...... with peritoneal dissemination.
@en
Consensus statement on the loc ...... with peritoneal dissemination.
@nl
P2093
P356
P1476
Consensus statement on the loc ...... with peritoneal dissemination.
@en
P2093
Dario Baratti
Dominique Elias
Jesus Esquivel
Marcello Deraco
Shigeki Kusamura
P304
P356
10.1002/JSO.21053
P577
2008-09-01T00:00:00Z